U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H45N9O10S2
Molecular Weight 731.841
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of (PGLU4,CYT6)OXYTOCIN 4-9

SMILES

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CSSC[C@H](N)C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCC(=O)N2)C(=O)NCC(N)=O

InChI

InChIKey=PWEAEIPNFANUJR-DYKIIFRCSA-N
InChI=1S/C28H45N9O10S2/c1-13(2)8-16(23(41)32-10-21(31)39)35-26(44)19-4-3-7-37(19)27(45)18(12-49-48-11-14(29)28(46)47)36-25(43)17(9-20(30)38)34-24(42)15-5-6-22(40)33-15/h13-19H,3-12,29H2,1-2H3,(H2,30,38)(H2,31,39)(H,32,41)(H,33,40)(H,34,42)(H,35,44)(H,36,43)(H,46,47)/t14-,15-,16-,17-,18-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C28H45N9O10S2
Molecular Weight 731.841
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 01:20:04 GMT 2025
Edited
by admin
on Wed Apr 02 01:20:04 GMT 2025
Record UNII
T88CX64XWL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(PGLU4,CYT6)OXYTOCIN 4-9
Common Name English
OT(4-9)
Preferred Name English
GLYCINAMIDE, 5-OXO-L-PROLYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LEUCYL-, DISULFIDE WITH L-CYSTEINE
Systematic Name English
Code System Code Type Description
CAS
84953-80-0
Created by admin on Wed Apr 02 01:20:04 GMT 2025 , Edited by admin on Wed Apr 02 01:20:04 GMT 2025
PRIMARY
PUBCHEM
154731588
Created by admin on Wed Apr 02 01:20:04 GMT 2025 , Edited by admin on Wed Apr 02 01:20:04 GMT 2025
PRIMARY
FDA UNII
T88CX64XWL
Created by admin on Wed Apr 02 01:20:04 GMT 2025 , Edited by admin on Wed Apr 02 01:20:04 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE ACTIVE
Does not bind to Oxytocin Receptor but leads to significant social preference in the BALB/cByJ model, in a dose-dependent manner. The increased sociability was observed at both 24?h and 12 days following the end of a subchronic regimen with OT(4–9) (2.0?mg/kg).